USE OF ENREROCOCCUS FAECIUM STRAINS FOR CURING HEPATIC DEFICIENCY AND FOR REGENERATING AND INTENSIFYING HEPATIC METABOLISM

摘要

The invention relates to the use of enrerococcus faecium (VKPM B-3490) and enrerococcus faecium M-3185 (VKPM B-349i) strains, a composition and a Bilaktin preparation based on said strains for curing a hepatic insufficienc y which is exhibited by hepatodepressive, cytolytic and cholestatic syndromes and by intrahepatic portal hypertension during hepatic diseases and liver injury, for liver regeneration, preventing overstress in extreme environment al conditions, for improving the aerobic productivity of an organism, for increasing a lipid participation in energy supply and for improving correlation between a muscle and fatty mass. Said invention also relates to a method for treating and preventing a hepatic insufficiency exhibited by hepatodepressive, cytolytic and cholestatic syndromes and by intrahepatic portal hypertension during hepatic diseases and liver injury and to a method for improving the aerobic productivity of an organism, for increasing a lipi d participation in energy supply and for improving the relation between a musc le and fatty mass.